CMS finalizes rule to streamline Medicare prior authorizations

The Centers for Medicare & Medicaid Services (CMS) has finalized a rule to reduce administrative burdens from prior authorization requirements in Medicare Advantage plans. The policy aims to speed up approvals and improve patient access to care. It will affect millions of enrollees starting in 2026.

FDA issues final rule on clinical trials diversity

30 settembre 2025 Riportato dall'IA

The U.S. Food and Drug Administration has finalized a rule requiring drug sponsors to submit diversity action plans for clinical trials. This aims to ensure better representation of underrepresented groups in medical research. The rule takes effect in 2025.

CMS proposes rule to protect Medicaid enrollees from improper terminations

02 ottobre 2025 Riportato dall'IA

The Centers for Medicare & Medicaid Services has issued a proposed rule to strengthen safeguards for Medicaid eligibility determinations. This move addresses widespread coverage losses during the post-pandemic unwinding process. The rule aims to ensure states comply with federal requirements for notices and appeals.

Senate confirms Robert Califf as FDA commissioner

The U.S. Senate has confirmed Robert Califf to lead the Food and Drug Administration amid ongoing public health challenges. Califf, a cardiologist with prior FDA experience, was approved in a bipartisan vote. This move aims to stabilize the agency during debates over drug approvals and regulations.